TACI, Fc-Fusion (IgG1), Avi-Tag Recombinant

Catalog #
100283
$320 *
Size: 100 µg
Qty
*US Pricing only. For international pricing, please contact your local distributor.
Purchase
Description

Recombinant human TACI (Tumor necrosis factor receptor superfamily member 13B, encoded by the TNFRSF13B gene), encompassing amino acids 23-166. This protein is fused at the C-terminus with the Fc fragment of human IgG1 followed by an Avi-Tag™. The recombinant protein was affinity purified.

Synonyms
TR13B, CVID, RYZN, TACI, CD267, CVID2, IGAD2, TNFRSF14B
Product Info
Storage and Usage
Citations
Species
Human
Construct
TACI (23-166-Fc(lgG1)-Avi)
Host Species/Expression System
HEK293
Purity

≥90%

Supplied As
Aqueous buffer solution.
Formulation
8 mM Phosphate, pH 7.4, 110 mM NaCl, 2.2 mM KCl, and 20% glycerol.
MW
45 kDa
Amino Acids
23-166
Genbank #
NM_012452
UniProt #
O14836
Tag(s)
C-terminal Fc-Avi-Tag
Background

TACI is a lymphocyte-specific member of the TNF (Tumor necrosis factor) receptor superfamily, which regulates B and T cell function and humoral immunity. This receptor binds to ligands APRIL and BAFF, two ligands that also bind to BCMA (B-cell maturation antigen) to induce B cell proliferation. TACI induces antibody responses and plasma cell differentiation, and it counteracts BAFF-driven B cell activation. Upon ligand binding, TACI interacts with CAML (calcium-modulator and cyclophilin ligand) to promote calcineurin-dependent activation of transcription factor NFAT (Nuclear Factor of Activated T cells). Although they do not directly cause disease, mutations in the TNFRSF13B gene predispose patients with CVID (common variable immunodeficiency) to autoimmune and immune cell proliferation disorders.

References
  1. Coste, A.T., et al., Eukaryotic Cell. 2004; 3(6): 1639-1652.
  2. Smith, S.T. et al., Nature Cell Bio. 2004; 6: 162-167.